Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA

Human Gene Therapy

Volumn 8, Issue 8, 1997, Pages 903-909

  Zhao, Shi Cheng ^a   Banerjee, Debabrata ^a   Mineishi, Shin ^a   Bertino, Joseph R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DIHYDROFOLATE REDUCTASE; METHOTREXATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TOXICITY; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CANCER TRANSPLANTATION; CELL PROTECTION; COLONY FORMING UNIT GM; CONTROLLED STUDY; DRUG RESISTANCE; DRUG TOLERABILITY; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; MOUSE; MULTIMODALITY CANCER THERAPY; NONHUMAN; RETROVIRUS; STEM CELL; SURVIVAL TIME; THROMBOCYTE COUNT;

EID: 0030999647     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.8-903     Document Type: Article

References (30)

1. ALLAY, J., DUMENCO, L., KOC, O.N., LIU, L., and GERSON, S.L. (1995). Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 85, 3342-3351.
2. BANERJEE, D., SCHWEITZER, B.I., VOLKENANDT, M., LI, M-X., WALTHAM, M., MINEISHI, S., ZHAO, S-C., and BERTINO, J.R. (1994). Transfection with a cDNA encoding a Ser31 or Ser34 mutant human DHFR into CHO and mouse marrow progenitor cells confer MTX resistance. Gene 139, 269-274.
3. BERTINO, J.R. (1979). Toward improved selectivity in cancer chemotherapy. Cancer Res. 39, 293-304.
4. CHUNDURU, S.K., CODY, V., LUFT, J.R., PANGHORN, W., APPELBAUM, J.R., and BLAKLEY, R.L. (1994). Methotrexate resistant variants of human dihydrofolate reductase. J. Biol. Chem. 269, 9547-9555.
5. COREY, C.A., DESILVA, A.D., HOLLAND, C.A., and WILLIAMS, D.A. (1990). Serial transplantation of MTX resistant bone marrow; protection of murine recipients from drug toxicity by progeny of transduced stem cells. Blood 76, 337-343.
6. DICKER, A.P., VOLKENADT, M., SCHWEITZER, B.I., BANERJEE, D., and BERTINO, J.R. (1990). Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate resistant Chinese hamster ovary cell line Pro-3 MTXRIII. J. Biol. Chem. 265, 8317-8321.
7. ERCIKAN-ABALI, E.A., WALTHAM, M.C., DICKER, A.P., SCHWEITZER, B.I., GRITSMAN, H., BANERJEE, D., and BERTINO, J.R. (1996a). Variants of human dihydrofolate reductase with substitutions at leucine-22: Effect on catalytic and inhibitor binding properties. Mol. Pharmacol. 49, 430-437.
8. ERCIKAN-ABALI, E.A., MINEISHI, S., TONG, Y., NAKAHARA, S., WALTHAM, M.C., BANERJEE, D., CHEN, W., SADELAIN, M., and BERTINO, J.R. (1996b). Active site directed double mutants of dihydrofolate reductase. Cancer Res. 56, 4142-4145.
9. FLASSHOVE, M., BANERJEE, D., MINEISHI, S., LI, M-X., BERTINO, J.R., and MOORE, M.A.S. (1995). Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 85, 566-574.
10. GALSKI, H., SULLIVAN, M., WILLINGHAM, M.C., CHIN, K.V., GOTTESMAN, M.M., PASTAN, I., and MERLINO, G.T. (1989). Expression of a human multidrug resistance CDNA(MDR-1) in the bone marrow of transgenic mice: Resistance to daunomycin induced leukopenia. Mol. Cell. Biol. 9, 4357-4363.
11. HANANIA, E.G., FU, S., RONINSON, I., ZU, Z., GOTTESMAN, M.M., and DEISSEROTH, A.B. (1995). Resistance to taxol chemotherapy produced by safety-modified retroviruses containing a human mdr-1 transcription unit. Gene Ther. 2, 279-284.
12. HUSSEIN, A., LEWIS, D., YU, M., and MELERA, P.W. (1992). Construction of a dominant selectable marker using a novel dihydrofolate reductase. Gene 112, 179-188.
13. LETOURNEAU, S., GREENBAUM, M., and COURNOYER, D. (1996). Retrovirus mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells. Hum. Gene Ther. 7, 831-840.
14. LI, M-X., HANTZOPOULOS, P.A., BANERJEE, D., ZHAO, S-C., SCHWEITZER, B.I., GILBOA, E., and BERTINO, J.R. (1992). Comparison of the expression of a mutant dhfr under the control of different internal promoters in retroviral vectors. Hum. Gene Ther. 3, 381-390.
15. LI, M-X., BANERJEE, D., ZHAO, S-C., SCHWEITZER, B.I., MINEISHI, S., GILBOA, E., and BERTINO, J.R. (1994). Development of a retroviral construct containing a human mutated dhfr cDNA for hematopoietic stem cell transduction. Blood 83, 3403-3408.
16. MAGNI, M., SHAMMAH, S., SCHIRO, R., MELLADO, W., DALLAFAVERA, R., and GIANNI, M.A. (1996). Induction of Cyclophosphamide resistance by Aldehyde dehydrogenase gene transfer. Blood 87, 1097-1103.
17. MAY, C., GUNTHER, R., and MCIVOR, R.S. (1995). Protection of mice from lethal doses of methotrexate by transplantation with transgenic marrow expressing drug-resistant dihydrofolate reductase activity. Blood 86, 2439-2448.
18. MCLACHLIN, J.R., EGLITIS, M.A., UEDA, K., KANTOFF, P.W., PASTAN, I.H., ANDERSON, W.F., and GOTTESMAN, M.M. (1990). Expression of a human cDNA for mdr gene in murine hematopoietic precursor cells with the use of retroviral gene transfer. J. Natl. Cancer Inst. 82, 1260-1263.
19. MOMPARLER, R.L., ELIPOULOS, N., BOVENZI, V., LETOURNEAU, S., GREENBAUM, M., and COURNOYER, D. (1996). Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells. Cancer Gene Ther. 3, 331-338.
20. MORITZ, T., MACKAY, W., GLASSNER, B., WILLIAMS, D.A., and SAMSON, L. (1995). Retrovirus mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea induced toxicity in vitro and in vivo. Cancer Res. 55, 2608-2614.
21. MORRIS, J.A., and MCIVOR, R.S. (1994). Saturation mutagenesis of dihydrofolate reductase at codons 22 and 31. Biochem. Pharmacol. 47, 1207-1220.
22. PODDA, S., WARD, M., HIMELSTEIN, A., RICHARDSON, C., DELA FLOR-WEISS, E., SMITH, L., GOTTESMAN, M., PASTAN, I., and BANK, A. (1992). Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Sci. USA. 89, 9676-9680.
23. SCHMID, F.A., SIROTNAK, F.M., OTTER, G.M., and DEGRAW, J.I. (1987). New folate analog: Activity of 10-ethyl-10-deaza aminopterin compared to MTX with 5FU and alkylating agents against advanced metastatic disease in murine tumor models. Cancer Treat. Rep. 71, 727-732.
24. SCHWEITZER, B.I., SRIMATKANDADA, S., GRITSMAN, H., SHERIDAN, R., VENKATARAGHAVAN, R., and BERTINO, J.R. (1989). Probing the role of two hydrophobic active site residues in dihydrofolate reductase by site directed mutagenesis. J. Biol. Chem. 264, 20786-20795.
25. SIMONSEN, C.C., and LEVINSON, A.D. (1983). Isolation and expression of an altered mouse dihydrofolate reductase cDNA. Proc. Natl. Acad. Sci. USA. 80, 2495-2499.
26. SORRENTINO, B.P., BRANDT, S.J., BODINE, D., GOTTESMAN, M., PASTAN, I., CLINE, A., and NIENHUIS, A.W. (1992). Selection of drug resistant bone marrow cells in vitro after retroviral transfer of human mdr-1. Science 257, 99-103.
27. SPENCER, H.T., SLEEP, S.E.H., REGH, J.E., BLAKLEY, R.L., and SORRENTINO, B.P. (1996). A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87, 2579-2587.
28. SRIMATKANDADA, S., SCHWEITZER, B.I., MOROSON, B.A., DUBE, S., and BERTINO, J.R. (1989). Amplification of a polymorphic dihydrofolate reductase gene expressing an enzyme with a decreased binding to MTX in a human colon carcinoma cell line HCT-8R4, resistant to this drug. J. Biol. Chem. 264, 3524-3528.
29. + cells. Blood 84, 1408-1414.
30. WILLIAMS, D.A., HSIEH, K., DESILVA, A., and MULLIGAN, R.C. (1987). Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate resistant bone marrow. J. Exp. Med. 166, 210-218.